Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06188208
Title A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130850 in Participants With Advanced Solid and Hematologic Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Vividion Therapeutics, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ESP | AUS

Facility Status City State Zip Country Details
Florida Cancer Specialists RECRUITING Sarasota Florida 34232 United States Details
Sarah Cannon Research Institute RECRUITING Nashville Tennessee 37203 United States Details
NEXT Austin RECRUITING Austin Texas 78758 United States Details
MDACC RECRUITING Houston Texas 77030 United States Details
NEXT Dallas RECRUITING Irving Texas 75039 United States Details
NEXT San Antonio RECRUITING San Antonio Texas 78299 United States Details
University of Utah Huntsman Cancer Institute RECRUITING Salt Lake City Utah 84112 United States Details
NEXT Virginia RECRUITING Fairfax Virginia 22031 United States Details
Blacktown Hospital RECRUITING Blacktown New South Wales Australia Details
Cancer Research South Australia RECRUITING Adelaide Australia Details
ICON Cancer Research RECRUITING South Brisbane Australia Details
START Barcelona Hospital HM Nou Delfos RECRUITING Barcelona Spain Details
NEXT Madrid RECRUITING Madrid Spain Details
START Madrid CIOCC RECRUITING Madrid Spain Details
Start Madrid-FJD, Hospital Fundacion Jimenez Diaz RECRUITING Madrid Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field